The invention relates to a compound targeting PDE4B
enzyme and application thereof, in particular to a compound with a structure shown in a general formula (I) or a stereoisomer, a
tautomer, a pharmaceutically acceptable salt, a
hydrate or a solvate thereof, in the formula (I), Y and Z are independently selected from none or # imgabs0 #, R11 is selected from H,
alkyl, chlorinated
alkyl and C5-C6 rings; r1 and R2 are independently selected from H,
alkyl containing a
substituent group or not containing a
substituent group, and C3-C10 rings containing a
substituent group or not containing a substituent group, wherein the substituent groups comprise
halogen,
amide, amino, hydroxyl, carboxyl, nitro, cyano, alkyl, alkoxy, alkylthio, C3-C10 cycloalkyl, C4-C10 heterocycloalkyl, C6-C10
aryl or C5-C10 heteroaryl; and R3 is selected from H, a C1-C20 alkyl group, a C1-C20 hetero-alkyl group, a C3-C10 cycloalkyl group, a C4-C10 hetero-alkyl group, a C6-C10
aryl group and a C5-C10 hetero-
aryl group which contain or do not contain a substituent group. # imgabs1 #